Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Ryan T. Babcock
ID:
1b83aa16-2619-30fb-68c4
/
Unclaimed
/
Organization:
Mayer Brown
Published Works
4 articles
Federal Circuit Invalidates Patent Term Adjustments for Obviousness-Type Double Patenting
Immuno-Innovation ·
August 31, 2023
cite
During a Public Health Emergency Should Patents Covering Vaccine Development Be Treated as Standard Essential Patents? (Part 2 of 2)
Immuno-Innovation ·
April 10, 2023
cite
During a Public Health Emergency Should Patents Covering Vaccine Development Be Treated as Standard Essential Patents? (Part 1 of 2)
Immuno-Innovation ·
December 19, 2022
cite
Does the PTAB’s Recent Ex Parte Cellect Decision Signal Concern for the Valuable Patent Terms of Biopharmaceuticals?
Immuno-Innovation ·
April 18, 2022
cite
